Keywords
endometriosis, endometriosis-associated ovarian cancer, WGCNA, machine learning
algorithms
Posted Date: February 7th, 2023
DOI: https://doi.org/10.21203/rs.3.rs-2542861/v1
License: This work is licensed under a Creative Commons Attribution 4.0 International License.
Read Full License
Page 2/25
Abstract
Background: Endometriosis is a widespread disease in reproductive age. Epidemiological studies reported
that patients with endometriosis had an increased risk of developing endometriosis-associated ovarian
cancer (EAOC). The present study aimed to identify shared genes and key pathways that commonly
interacted between EAOC and endometriosis.
Methods
The expression matrix of ovarian cancer and endometriosis were collected from the Gene
Expression Omnibus database. The weighted gene co-expression network analysis (WGCNA) was used to
construct co-expression gene network. Functional enrichment analyses were conducted to clarify the
potential regulatory mechanisms. Protein-protein interaction (PPI) network and machine learning
algorithms were applied to identify characteristic genes. CIBERSORT deconvolution algorithm was used
to explore the difference in tumor immune microenvironment. Receiver operating characteristic curves
were utilized to assess the clinical diagnostic ability of hub genes. Furthermore, diagnostic nomogram
was constructed and evaluated for supporting clinical practicality.
Results
We identied 262 shared genes between EAOCand endometriosis via WGCNA analysis. They
were mainly enriched in cytokine-cytokine receptor interaction, which may be considered a common
mechanism between EAOC and endometriosis. After PPI network and machine learning algorithms, we
recognized two characteristic genes (EDNRA, OCLN) and established a nomogram that presented an
outstanding predictive performance. The hub genes demonstrated remarkable associations with
immunological functions. OCLN were highly upregulatedin ovarian cancer compared to non-tumor
tissues, while expression levels of EDNRA were signicantly downregulated in ovarian cancer samples.
Survival analysis indicated that dysregulated expressions of EDNRA and OCLNwere closely correlated
with prognosis of ovarian cancer patients. GSEA analyses revealed that the two characteristic genes were
mainly enriched in the cancer- and immune-related pathways. Gene drug interaction analysis found 15
drugs compound that interacted with the hub genes.
Conclusion
We identied two hub genes (EDNRA, OCLN) and constructed a nomogram to predict the risk
of EAOC based on WGCNA analyses and machine learning algorithms. They can be used as effective
predictive biomarkers for detecting EAOC. Our ndings pave the way for further investigation of potential
candidate genes and will aid in improving the diagnosis and treatment of EAOC in endometriosis
patients.
Introduction
Endometriosis is a disease caused by the implantation of active and growing ectopic endometrium in the
ovary, commonly in women of childbearing age, which is benign but with invasive and recurrent
malignancy-like behavior [1, 2]. Epidemiological studies reported that patients with endometriosis,
especially ovarian endometriosis cysts, had an increased risk of developing epithelial ovarian cancer,
signicantly higher than the general population, and 0.7%-2.5% of endometriosis was associated with
Page 3/25
malignant transformation to endometriosis-associated ovarian cancer (EAOC) [3, 4]. The main clinical
features of patients at risk of endometriosis malignancy are: (i) a long history of endometriosis (> 10
years); (ii) having endometriosis at an early age; (iii) a history of endometriosis-related infertility and/or
infertility treatment; and (iv) ovarian endometriosis cysts. Sampson originally proposed the criteria of
EAOC caused by endometriosis included that the tumor needed to be situated next to unequivocal foci of
endometriosis, no other primary tumor present, and the presence of tissues similar to endometrial stroma
surrounding epithelial glands [5]. Growing number of evidences demonstrated that atypical endometriosis
was a precancer lesion for ovarian cancer [6–8]. EAOC patients have a relatively early age of onset and
early clinical stage, with the proportion of stage I patients accounting for approximately 54.2%. Age
factors, economic status, depression, pelvic inammatory disease, and endometriosis-related infertility
are high-risk factors for EAOC.
The development of sequencing technologies and bioinformatics has made it possible to investigate the
genetic pathogenesis of disease-disease interactions. This study aimed to identify the co-expression
genes modules and shared genes of EAOC and endometriosis via weighted gene co-expression network
analysis (WGCNA) [9] and machine learning algorithms. WGCNA enables the reconstruction of gene
regulatory networks and the identication of modules of genes with similar expression patterns. By
integrating gene expression data with other omics data, WGCNA provides a comprehensive view of gene
interactions and can help to uncover the underlying biological pathways involved in complex diseases
[10, 11]. Machine learning algorithm has been utilized to identify characteristic genes for several diseases
[12, 13]. Support vector machine - recursive feature elimination (SVM-RFE) [14] algorithm eliminates
superuous variables and retains only those variables that are relevant to the results. Least absolute
shrinkage and selection operator (LASSO) [15] logistic regression is commonly utilized to narrow down
variables and identify the most appropriate λ for categorization. Random forest (RF) [16] is used to work
with high-dimensional data, construct predictive model and predict the importance of each variable. It is
generally accepted that bioinformatics and machine learning algorithms can be effectively employed to
identify shared genes and biomarkers for forecasting EAOC.
Our study revealed that EAOC and endometriosis shared 262 genes. They were mainly enriched in
cytokine-cytokine receptor interaction, which may be considered a common mechanism between EAOC
and endometriosis. After machine learning algorithm in the conrmation cohort, we identied two hub
genes (EDNRA, OCLN) and established a nomogram. They can be used as effective predictive biomarkers
for detecting occult EAOC in endometriosis patients. Additionally, the dysregulated degree of immune cell
inltration and association of hub genes with immune cells were initially discussed.
Material and methods
Data sources and preprocessing
The expression proles of ovarian carcinoma were collected from the Gene Expression Omnibus (GEO)
database. In total, four available datasets were collected via R package “GEOquery”. The high throughput
Page 4/25
sequencing dataset GSE157153 including 29 ovarian carcinoma tissues and 37 endometriosis tissues
was used to explore the shared genes between endometriosis and endometriosis-associated ovarian
cancer (EAOC). GSE5108 contained 11 ectopic endometrial samples and 11 eutopic endometrial tissues,
GSE18520 consisted of 53 ovarian adenocarcinoma tissues and 10 normal ovary samples. Both of them
were utilized to conrm the shared genes. Furthermore, the expression matrix of malignant ovarian
samples from The Cancer Genome Atlas (TCGA) dataset and expression prole of normal ovarian tissues
from the Genotype-Tissue Expression (GTEx) also served as a validation dataset. The study owchart is
shown in Fig. 1.
WGCNA
We constructed co-expression gene networks of endometriosis and EAOC using WGCNA in order to
investigate the underlying biological processes and common genes involved in disease progression. The
data were preprocessed by calling the "WGCNA" function package, and the "goodsamplegenes()" function
was used to check whether there were abnormal genes in the data and select appropriate thresholds to
reject outliers. The clinical feature data were loaded, and the gene-feature clustering tree was drawn to
complete the construction of the co-expression network and the selection of modules. The
"pickSoftThreshold" algorithm chose an appropriate "soft" threshold ( β ) to calculate the adjacency matrix
and to obtain a biologically signicant scale-free network. The clustering dendrogram was drawn for
module selection, and the minimum module capacity and module shear height were set to merge
modules with high similarity. The EAOC gene set in the modules that were highly correlated with ovarian
carcinoma. Scatter plots of gene signicance (GS) and module membership (MM) in the signicant co-
expression modules were plotted to clarify the signicance of genes in the selected modules.
Functional enrichment analysis
Gene set enrichment analysis (GSEA) was performed to clarify the potential regulatory mechanisms
responsible for the disease progression of endometriosis to EAOC, and the gene set
(“c2.cp.kegg.v7.4.symbols.gmt”) were obtained from the Broad Institute database. Gene Ontology (GO)
and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment were also conducted.
Gene Set Variation Analysis (GSVA) was utilized to reveal the differences in signaling pathways between
the endometriosis and EAOC by "GSVA" R package. The selected gene set “h.all.v7.4.symbols.gmt” was
got from the Molecular Signature Database (MSigDB). All these analyses were performed via R packages
“limma”, “clusterProler”, “gseaplot2”, and “ggplot2”.
Conrmation of shared genes in endometriosis and EAOC
To conrm the shared genes in endometriosis and EAOC, we applied the differentially expressed gene
(DEGs) analysis in conrmation dataset GSE157153 including both endometriosis and EAOC tissues with
the cutoff value of adjusted p 1 via “limma” package. The overlap of
above shared genes from WGCNA analyses of GSE5108 and GSE18520 and DEGs in the conrmation
Page 5/25
cohort GSE157153 were presented by a Venn diagram using EVenn (http://www.ehbio.com/test/venn/#/)
online tool.
Identication of hub genes from protein-protein interaction
network
The STRING database was used for protein interaction analysis for a set of shared genes and the results
were imported into the Cytoscape software to investigate the target modules and hub genes from the
protein-protein interaction (PPI) network. An interaction score with a condence level of 0.4 was used as
the cutoff criterion for construction and unconnected nodes were hidden. Then we utilized four different
algorithms (Closeness, Betweenness, MCC, and Degree) via the CytoHubba plugin to identify the top 30
hub shared genes.
Machine learning algorithm
Three machine learning algorithms including SVM-RFE, RF, and LASSO regression analysis were used to
investigate the effectiveness of 23 shared DEGs via packages of “msvmRFE.R”, “caret”, and “glmnet”.
These algorithms were performed to carry out the binary classication of the data through supervised
learning method. Receiver operating characteristic (ROC) curves were calculated based on 23 common
genes from the GSE157153 transcriptome dataset, and area under the ROC curves (AUCs) were used to
evaluate the diagnostic ability of commonly shared genes from the three classication algorithms. The
dataset was randomly divided into training cohort and test cohort in a ratio of 4:1.
Nomogram construction
The common genes obtained as a result of the three classication algorithms were combined to
construct the nomogram via “rms” package. The consistence between the nomogram − predicted
probability of nonadherence and the actual results were evaluated by calibration curves. We also used
decision curve analysis (DCA) to summarize the performance of our shared gene constructed model and
to evaluate whether this model has utility in supporting clinical decisions. All these analyses were
performed via R packages “VRPM”, “rmda”, “ggDCA”, “rms”, and “ggplot2”.
Expression prole and survival analysis of shared genes
between endometriosis and EAOC
We calculated the different expression of shared genes between endometriosis and EAOC in the
GSE157153 dataset. Then, these expression proles were evaluated in the GSE18520 and TCGA-OV
database. Boxplot was utilized to present the differential expression of these genes. Furthermore, the
overall survival of these shared genes was compared by Kaplan-Meier method according to the package
“survminer” and “survival”. An adjusted p-value < 0.05 was considered statistically signicant.
Tumor microenvironment cell inltration analyses
Page 6/25
To quantify the relative proportion of immune cells in endometriosis cohort and EAOC cohort, CIBERSORT
deconvolution algorithm was used to evaluate the immune inltration proportion of 22 immune cell
subtypes in accordance to the gene expression values. Spearman correlation analysis was used to
display the association between immune inltration proportion of immune cells and the expression of
hub genes.
Predicting regulatory targets of transcription factor
The JASPAR TF binding site prole database was used to identify transcription factors (TFs) that bound
to shared genes. Additionally, shared genes regulation-related miRNA that negatively correlated with
protein expression were predicted by TarBase (v8.0). The topology networks of TFs-gene and miRNA-gene
were constructed based on the NetworkAnalyst platform.
Evaluation of clinical diagnostic ability of shared genes
ROC curves and AUCs were utilized to assess whether shared genes could well distinguish EAOC patients
from control group via “pROC” package in GSE157153. Additionally, GSE18520 and TCGA-OV datasets
were used to assess and explore the shared genes with the most clinical diagnostic ability.
The protein expressions and shared genes between
endometriosis and EAOC
The Human Protein Atlas (HPA) database (https://www.proteinatlas.org/) mapped all the human proteins
in cells, tissues and organs by integrating multiple omics technologies. We searched the representative
images of immunohistochemistry showing shared genes expression in endometriosis and EAOC tissues.
Gene–Drug interaction analysis
Although there is promising development of novel therapeutic drugs for ovarian cancer, the prognosis of
ovarian cancer is often poor. In the present study, we searched the drug-gene interaction database
(DGIdb) for potential drugs that interacted with common genes between endometriosis and EAOC.
Results
Identication of signicant modules via WGCNA
We executed WGCNA to identify co-expressed gene modules in endometriosis- and EAOC-related
datasets. Based on scale independence of > 0.8, the best soft threshold ( β ) was 4 for GSE5108 to ensure
biologically signicant scalefree topology and we found the same soft threshold for GSE18520 (Fig. 2A,
2B). GSE5108 and GSE18520 co-expression networks were separated into 14 and 6 modules,
respectively. Figure 2C and Fig. 2D presented the co-expression modules clustering in endometriosis and
ovarian cancer. Each branch represented each gene, and genes clustered into the same module were
assigned the same color. As depicted in Fig. 2F, correlation heatmaps of module eigengene values with
clinical traits revealed that the Blue and Brown modules were highly correlated with EAOC, while Black
Page 7/25
and Grey modules were predominantly associated with endometriosis (Fig. 2E). Therefore, we identied
and intersected the hub modules to obtain the shared genes between endometriosis and EAOC patients.
Finally, 362 common genes were selected for further investigation.
GO and KEGG pathway enrichment analysis
GO and KEGG pathway enrichment were used based on these 362 common genes between
endometriosis and ovarian cancer. GO enrichment analysis consisted of biological process (BP), cell
composition (CC) and molecular function (MF) analysis. BP mainly correlated with leukocyte cell-cell
adhesion and regulation of leukocyte proliferation. CC was mainly associated with apical part of cell and
collagen-containing extracellular matrix. The MF was mainly related to peptidase regulator activity and
endopeptidase regulator activity (Fig. 3A). The KEGG pathway showed that these shared genes were
mainly enriched in the cytokine-cytokine receptor interaction, intestinal immune network for lgA
production, and IL-17 signaling, indicating that these common genes may be involved in tumorigenesis
and tumor progression in ovarian cancer (Fig. 3B).
Conrmation of shared genes between endometriosis and
EAOC
To conrm shared genes between endometriosis and EAOC, we performed the differentially expressed
gene (DEGs) analysis in conrmation dataset GSE157153, which included both endometriosis and EAOC
tissues, using the cutoff value of adjusted p 1. We identied 1316
upregulated and 1662 downregulated DEGs from these data (Fig. 3C). Heatmap showed the top 30 up-
regulated and down-regulated DEGs in endometriosis and EAOC (Fig. 3D). The shared genes in
endometriosis and EAOC were then intersected with these DEGs. Finally, we obtained a total of 116
common genes, which may play crucial role in both endometriosis and EAOC (Fig. 3E).
Protein-protein interaction network construction
A PPI network of potential targets was constructed via the STRING online database, and a total of 116
common genes were visualized by Cytoscape software. Using the CytoHubba plugin and four distinct
algorithms (Closeness, Betweenness, MCC, and Degree), we identied the top 30 shared genes (Fig. 3F).
Finally, 23 node genes were selected from this network for subsequent analysis.
Machine learning algorithms for hub genes selection
Three classication algorithms were applied in this study to further investigate shared genes between
endometriosis and EAOC for potential biomarkers from 23 potential genes. Twelve genes were found to
have the lowest binominal deviation using the LASSO regression algorithm (Fig. 4A, 4B). SVM-RFE
analysis revealed that the model incorporating four genes owing the lowest error (Fig. 4D). Based on the
importance score provided by the RF algorithm, the top ten genes were chosen and ordered. (Fig. 4C, 4E).
Finally, two hub genes (EDNRA and OCLN) were selected for the nomogram construction and diagnostic
ability evaluation. A Venn diagram was used to display the intersected genes of three machine learning
algorithms (Fig. 4F).
Page 8/25
Nomogram construction and assessment of diagnostic
ability of hub genes
The diagnostic nomogram was constructed and presented that the expression of two characteristic
genes contributed to the clinical diagnosis of EAOC. By integrating the scores corresponding to the
relative expression of each gene, the probability of a patient being diagnosed with EAOC was calculated
(Fig. 5A). Calibration plots demonstrated the diagnostic nomogram's strong prognostic value (Fig. 5B). To
evaluate the clinical practicality of our characteristic genes, DCA was performed, which integrated the
preferences of the patients or clinicians into consideration (Fig. 5C). In this analysis, clinical judgment of
the benets and harms related to diagnostic model will be made. We compared EDNRA, OCLN and
nomogram and found that nomogram demonstrated the best overall net benet across a wide and
practical range of threshold probabilities. This study may help clinicians make more accurate diagnoses
of patients with EAOC.
ROC curves and AUCs were utilized in GSE157153 to evaluate the diagnostic performance of EDNRA and
OCLN. The results showed each gene to have exceptional predictive performance as shown below.: OCLN
(AUC: 0.991, 95%CI: 0.976–1.000, Fig. 5D); EDNRA (AUC: 0.922, 95%CI: 0.850–0.993, Fig. 5E); Nomogram
(AUC: 0.993, 95%CI: 0.982–1.000, Fig. 5F). The result showed that the nomogram consisting of EDNRA
and OCLN presenting the best predictive performance and acting a potential diagnostic biomarker for
EAOC. GSE18520 was utilized to validate the diagnostic value and the results showed that the AUCs of
OCLN, EDNRA, and Nomogram were 0.789, 0.860, and 0.900 respectively via ROC curve analyses (Fig. 5J-
L). Furthermore, TCGA-OV was also used to evaluate the predictive performance of EDNRA and OCLN.
The ROC analyses yielded the AUCs of 0.995, 0.867, and 0.996 for OCLN, EDNRA, and Nomogram
respectively, demonstrating good clinical diagnostic ability (Fig. 5G-I).
Immune inltration analysis
To compare the difference in immune inltration landscape between endometriosis and EAOC patients,
we evaluated the inltration levels of the immune cells, immune checkpoint molecular. CIBERSORT
deconvolution algorithm demonstrated that the immune inltration levels of plasma cells, T cells
follicular helper, Macrophages M1, and Mast cells activated were signicantly elevated while CD8+ T
cells, NK cells activated, macrophages M2, and mast cells resting were remarkably decreased in EAOC
group (Fig. 6A). Correlation analysis showed that T cells CD4 memory resting had the greatest positive
correlation with CD8+ T cells, while B cells memory displayed the highest negative correlation with T cells
regulatory (Tregs) (Fig. 6D). Furthermore, spearman correlation analyses were conducted to investigate
the expression values of hub genes with immune cell inltration degree and the results showed that
OCLN was positively correlated with Tfh, macrophages M1, and mast cells activated, while negatively
correlated with CD8+ T cells, mast cells resting, and macrophages M2 (Fig. 6B). EDNRA was positively
correlated with mast cells resting, NK cells activated, and CD8+ T cells, and negatively correlated with
plasma cells, macrophages M1, T cells follicular helper (Tfh), and mast cells activated (Fig. 6C).
Page 9/25
GSVA of hallmark gene sets between EAOC and endometriosis and GSEA functional analysis of hub
genes
GSVA of hallmark gene sets between EAOC and endometriosis patients was performed in the GSE157153
dataset (Fig. 7C). The results showed that the MYC_TARGETS_V1, PI3K_AKT_MTOR_SIGNALING, and
P53_PATHWAY were activated, while NOTCH_SIGNALING, and TGF_BETA_SIGNALING were suppressed in
the progression from endometriosis to EAOC. Furthermore, GSEA analyses were utilized to evaluate
signaling pathways involved in the hub genes. We found that EDNRA and OCLN were mainly enriched in
the tumor-related pathways, including P53 signaling pathway, calcium signaling pathway, cell cycle, focal
adhesion, and MAPK signaling pathway (Fig. 7A, 7B). While OCLN were also associated with enrichment
in immune-related pathways, like systemic lupus erythematosus, cytokine–cytokine receptor interaction,
chemokine signaling pathway, and autoimmune thyroid disease (Fig. 7B).
Identication of TFs and miRNAs interacting with shared
genes
To investigate the regulatory mechanisms of shared genes OCLN and EDNRA in endometriosis and EAOC,
we used NetworkAnalyst tool to explore the TFs and miRNAs. In the TF-hub genes network, we found that
OCLN may be regulated by HNF4A, JUND, and SRF. EDNRA may be regulated by STAT3, FOXL1, and
CREB1(Additional le 1A). Additionally, miRNA-hub genes network demonstrated that has-mir-129-2-3p
may play core regulatory role. Through network analysis, the TFs and miRNAs connected to two
characteristic genes were shown in Additional le 1B.
The expression proles and protein expression of shared
genes
We compared the expression proles of the hub genes EDNRA and OCLN in patients with endometriosis
and EAOC, the results revealed that the expression values of EDNRA were profoundly downregulated
while the expression proles of OCLN were signicantly upregulated in ovarian cancer (Fig. 8A, 8B). The
above ndings were also evaluated and validated in the GSE18520 (Fig. 8C, 8D) and TCGA-OV cohorts
(Fig. 8E, 8F). To further investigate the protein expression of EDNRA and OCLN, we searched the
representative images of immunohistochemistry stainings from HPA and found that OCLN proteins
expression levels were signicantly elevated in ovarian carcinoma tissues when compared to normal
ovarian tissues, while EDNRA were remarkably overexpressed in normal ovarian samples when compared
to ovarian carcinoma samples (Fig. 8I), which were consistent with the expression patterns of mRNA. To
evaluate the correlation of expression proles of hub genes with prognosis of EAOC, Kaplan-Meier curves
were plotted to compare the overall survival difference between high- and low-expression groups. The
Results
demonstrated that EAOC patients in TCGA-OV dataset with upregulated expression of OCLN and
EDNRA showed signicant worse prognosis than those with downregulated expression of EDNRA and
OCLN (Fig. 8G, 8H).
Prediction of potential therapeutic drugs
Page 10/25
Drug-gene interaction analysis was performed to investigate the potential drugs that interact with two
shared genes between endometriosis and EAOC via the DGIdb database. We constructed drug-
corresponding hub genes networks and found 15 potential drugs, including sitaxentan, ambrisentan, and
bosentan. These potential drugs derived from hub genes may play a crucial role in elucidating the
mechanism of genes and cell function in relation to receptor sensitivity (Additional le 2).
Discussion
Endometriosis is a widespread disease in reproductive age. It causes chronic inammatory reaction that
may result in the formation of scar tissue within the pelvis. The expression of cytokines, which were
responsible for the inammatory response and its regulation, was shown to be affected by the
dysfunction of the immune system. The activation of immune cells triggered signaling pathways, caused
the release of inammatory cytokines and accumulated multiple cell types at the site of inammation
[17–19]. In the endometriotic environment, higher levels of IL-17, which modulates immune cells and
perpetuates chronic inammation, have been detected [20–22]. Recent research demonstrated that the
immune system actively contributed to the pathogenesis of ovarian cancer, and that local and systemic
immune responses determined tumor growth and clinical outcomes. Immunotherapy for gynecological
cancers may assist in reversing immunosuppression and lymphocyte depletion brought on by previous
treatments. Interestingly, the KEGG pathway showed that these sheard genes were mainly correlated with
the cytokine-cytokine receptor interaction, intestinal immune network for lgA production, and IL-17
signaling pathway. The GO enrichment analysis demonstrated the biological functions of these common
genes were enriched in regulation of immune cells proliferation. These results indicated that the immune
system played a crucial role in the progression of endometriosis and EAOC.
WGCNA is a systematic biological method that uses a topological overlap measure to construct a
network of genes based on their expression proles. WGCNA has been widely used to identify gene-gene
interactions, study gene expression patterns, and identify gene regulatory networks. It has also been
applied to a variety of biological problems, from cancer to cardiovascular disease. Herein, there were 14
endometriosis-related and 6 EAOC-related gene modules via WCGNA. The blue and brown modules
exhibited the highest correlation and were deemed EAOC-related modules, whereas the black and grey
modules were applied as endometriosis-related key modules. By intersecting the shared genes of
endometriosis-related and EAOC-related gene clusters, a total of 362 genes were obtained. Limma
analysis was utilized to identify DEGs in the conrmation cohort consisting both endometriosis and
EAOC patients. Then, we selected 23 DEGs after PPI network construction and analysis. After intersection
of three machine learning methods (SVM-RFE, LASSO, and RF), two hub DEGs (EDNRA and OCLN) were
chosen for nomogram construction and diagnostic ability evaluation for endometriosis patients with
EAOC. First, we identied two diagnostic biomarkers (EDNRA and OCLN) by integrating the scores
corresponding to the expression of hub genes. Then, we performed external validation using two
additional datasets, which revealed that the two hub genes had exceptional predictive performance for
EAOC in endometriosis patients, indicating their potential diagnostic roles during the tumorigenesis and
progression of EAOC.
Page 11/25
Endothelin (EDN) was initially isolated from cultured porcine aortic endothelial cells [23, 24]. EDN
receptors, namely endothelin A receptor (EDNRA) and endothelin B receptor (EDNRB), which belonged to
the G protein-coupled receptor family [25], mediated the biological actions of EDN. EDNRA was expressed
in both vascular and non-vascular tissues and regulated a wide range of physiological processes [26, 27].
A study on chemotherapeutic resistance of ovarian cancer found that the activation of EDNRA by EDN1
promoted a direct interaction between β -arr1 and β -catenin to regulate epigenetic modications driving
cancer chemoresistance onset. It also reported that the overexpression of EDNRA correlated with poor
prognosis, indicating EDNRA as a potential predictive marker of chemoresistance [28]. The survival rate
of EAOC patients with a high expression of EDNRA was also found to be lower in the present study.
Tight junctions are protein structures that regulate the transcellular transport of water, ions, and
macromolecules. OCLN, the rst tight junctions protein identied, is considered a necessary integral
protein for the structure and function of tight junctions [29]. Paku ł a et al. demonstrated that the
expression of junctional proteins, including OCLN, E-cadherin, and desmoglein, in peritoneal mesothelial
cells determined the integrity of the peritoneal mesothelium, which played critical role for the invasion of
ovarian cancer [30]. Tobioka et al. reported that in human endometrial carcinoma, OCLN expression
decreased proportionally with tumor grade and correlated with myometrial invasion and lymph node
metastases [31]. Forced expression of OCLN in human cervical carcinoma cells enhanced the sensitivity
of the cells to differently triggered apoptotic stimuli and thus inhibited the tumorigenic potencies of the
transformed cells and suppressed tumor development [32]. Martin et al. found that knockdown of OCLN
in human breast cancer cells lead to the profoundly increased invasive potential cells. In addition, the
absence of OCLN expression was linked to metastatic disease. And they concluded that OCLN was
necessary for the proper function of tight junctions in human breast epithelial cells [33].
Local and systemic immune responses determined tumor growth and clinical outcomes and had a
signicant impact on the pathogenesis of ovarian cancer. As a result, we compared the proportion of
immune cell inltrating in EAOC patients and found that the immune inltration levels of plasma cells,
Tfh, macrophages M1, and mast cells activated were signicantly elevated, while CD8+ T cells, NK cells,
macrophages M2, and mast cells resting were remarkably decreased. Previous research demonstrated
that CD8+ T cells were essential for tumor suppression and linked to better prognoses in a variety of
cancers [34]. NK cells are granular lymphocytes that play critical roles in the immune surveillance of
tumors. In patients with cancer, the degree of NK cell inltration in tumor tissues was prognostic, and a
reduced NK cell function was associated with worse outcome [35, 36]. The recent advancements in
ovarian cancer research showed that macrophage could enhance ovarian tumor progression, but due to
its high plasticity, it can also inhibit tumor growth by remodeling the M2-like phenotype to M1-like
phenotype, and the plasticity of macrophage can be exploited in ovarian cancer treatment [37, 38]. Tfh
are a subset of CD4+ T cells identied for the rst time in the human tonsil. They play an essential role in
protective immunity by assisting B cells in the production of antibodies against foreign pathogens.
Recent studies nd that mast cells have both tumor-promoting and tumor-inhibiting effects, and
compartmentalized by the microenvironment responsible for this effect [39]. Chan et al. demonstrated
Page 12/25
that high degree of mast cell inltration was correlated with better prognosis than low degree of
inltration in women with advanced ovarian cancer [40]. Moreover, our study revealed that there was
positive correlation between EDNRA expression level and activated CD8+ T cells and NK cells, indicating
that EDNRA was associated with enhancing the antitumor immune response. Combined with the
downregulated expression levels of EDNRA in EAOC patients, our study indicated that decreased EDNRA
levels were correlated with a suppressive immunophenotype in patients with EAOC. OCLN expression
level showed positive correlations with immune inltration degree of Tfh, macrophages M1, and mast
cells activated, Meanwhile, it was negatively correlated macrophages M2. Similar to EDNRA, the above
Results
also suggest that OCLN is associated with an activated immunophenotype. It is partially
conrmed that the increased OCLN expression level may be related to the enhanced activation of the
immune system when considering the expression pattern of OCLN in EAOC patients. However, the
functions of these hub genes in EAOC need further investigate by vitro and vivo experiments.
There were some limitations in this study. Firstly, the diagnostic biomarkers were constructed only on the
basis of public databases without real-world data validation. Therefore, further verication with
improvement in sample size, sequencing data, and clinical information is needed in the future. Secondly,
due to the distinct experimental designs for each dataset, the combination of various gene expression
datasets may be biased.
Conclusion
We identied two shared genes (EDNRA, OCLN) and developed a diagnostic nomogram to predict the risk
of EAOC patients with endometriosis via WGCNA analysis and machine learning algorithms. Cytokine-
cytokine receptor interaction was found to be a common signaling pathway between EAOC and
endometriosis. The correlation of hub genes with immune cells as well as the dysregulated level of
immune cell inltration were initially discussed. Collectively, the results of our research lay the
groundwork for further exploration of possible candidate genes and aid in the improvement of EAOC
diagnosis and treatment. However, more research is required to determine the exact mechanisms by
which these two hub genes affecting the development and progression of EAOC from endometriosis.
Abbreviations
AUCs: Area under the ROC curves
EAOC: Endometriosis-associated ovarian cancer
GSEA: Gene set enrichment analysis
GO: Gene Ontology
GSVA: Gene set variation analysis
Page 13/25
GEO, Gene Expression Omnibus
GTEx: Genotype-Tissue Expression
KEGG: Kyoto Encyclopedia of Genes and Genomes
Limma: Linear models for microarray data
LASSO: Least absolute shrinkage and selection operator
RF: Random forest
SVM-RFE: Support vector machine-recursive feature elimination
TCGA: The Cancer Genome Atlas
WGCNA: Weighted gene co-expression network analysis
TFs: Transcription factors
ROC: Receiver operating characteristic curve
Declarations
Ethics approval
Not applicable
Consent for publication
Not applicable
Availability of data and materials
The data during the present study is available from the corresponding authors on reasonable request.
Funding
This work was supported by grants from Medical Health Science and Technology Project of Zhejiang
Provincial Health Commission (2022KY303).
Author contributions
YM Du, YC Hu and FB Zhang conducted the data analyses; YM Du and TH Zhu drafted the manuscript;
YM Du, YC Hu, and YT Guan contributed to manuscript review. All the authors approved the nal
manuscript.
Page 14/25
Acknowledgments
None.
Conict of Interest
The authors have no conict of interest to disclose.
References
1. Taylor HS, Osteen KG, Bruner-Tran KL, Lockwood CJ, Krikun G, Sokalska A, Duleba AJ. Novel
therapies targeting endometriosis. Reprod Sci. 2011;18:814-823.
2. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril.
2012;98:511-519.
3. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PMet al.Berchuck A. Association
between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of
case-control studies. Lancet Oncol. 2012;13:385-394.
4. Hermens M, van Altena AM, Nieboer TE, Schoot BC, van Vliet H, Siebers AG, Bekkers RLM. Incidence
of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA
population-based cohort study. Am J Obstet Gynecol. 2020;223:107 e101-107 e111.
5. SAMPSON JA. ENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN
THAT ORGAN. Archives of Surgery. 1925;10:1-72.
. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng Tet al.Huntsman DG. ARID1A mutations in
endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363:1532-1543.
7. Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close
association with malignant epithelial tumours. Histopathology. 1997;30:249-255.
. Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi Ket al.Nakano H. Ovarian
endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical
study. Gynecol Oncol. 2000;77:298-304.
9. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC
Bioinformatics. 2008;9:559.
10. Guo X, Xiao H, Guo S, Dong L, Chen J. Identication of breast cancer mechanism based on weighted
gene coexpression network analysis. Cancer Gene Ther. 2017;24:333-341.
11. Feng S, Xu Y, Dai Z, Yin H, Zhang K, Shen Y. Integrative Analysis From Multicenter Studies Identies a
WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer. Front Immunol.
2022;13:951582.
12. Yu R, Zhang J, Zhuo Y, Hong X, Ye J, Tang S, Zhang Y. Identication of Diagnostic Signatures and
Immune Cell Inltration Characteristics in Rheumatoid Arthritis by Integrating Bioinformatic Analysis
and Machine-Learning Strategies. Front Immunol. 2021;12:724934.
Page 15/25
13. Zheng PF, Chen LZ, Liu P, Pan HW, Fan WJ, Liu ZY. Identication of immune-related key genes in the
peripheral blood of ischaemic stroke patients using a weighted gene coexpression network analysis
and machine learning. J Transl Med. 2022;20:361.
14. Sanz H, Valim C, Vegas E, Oller JM, Reverter F. SVM-RFE: selection and visualization of the most
relevant features through non-linear kernels. BMC Bioinformatics. 2018;19:432.
15. Tibshirani R. Regression shrinkage and selection via the lasso: a retrospective. Journal of the Royal
Statistical Society: Series B (Statistical Methodology). 2011;73:273-282.
1. Hu J, Szymczak S. A review on longitudinal data analysis with random forest. Brief Bioinform. 2023;
17. Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with
endometriosis. Hum Reprod Update. 2019;25:564-591.
1. Zhang T, De Carolis C, Man GCW, Wang CC. The link between immunity, autoimmunity and
endometriosis: a literature update. Autoimmun Rev. 2018;17:945-955.
19. Harada T, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril. 2001;76:1-10.
20. Hirata T, Osuga Y, Takamura M, Saito A, Hasegawa A, Koga Ket al.Taketani Y. Interleukin-17F
increases the secretion of interleukin-8 and the expression of cyclooxygenase 2 in endometriosis.
Fertil Steril. 2011;96:113-117.
21. Ahn SH, Edwards AK, Singh SS, Young SL, Lessey BA, Tayade C. IL-17A Contributes to the
Pathogenesis of Endometriosis by Triggering Proinammatory Cytokines and Angiogenic Growth
Factors. J Immunol. 2015;195:2591-2600.
22. Shi FD, Ljunggren HG, La Cava A, Van Kaer L. Organ-specic features of natural killer cells. Nat Rev
Immunol. 2011;11:658-671.
23. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin
family: three structurally and pharmacologically distinct isopeptides predicted by three separate
genes. Proc Natl Acad Sci U S A. 1989;86:2863-2867.
24. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Yet al.Masaki T. A novel potent
vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
25. Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JSet al.Maguire JJ. Endothelin.
Pharmacol Rev. 2016;68:357-418.
2. Bondurand N, Dufour S, Pingault V. News from the endothelin-3/EDNRB signaling pathway: Role
during enteric nervous system development and involvement in neural crest-associated disorders.
Dev Biol. 2018;444 Suppl 1:S156-S169.
27. Kohan DE, Rossi NF, Inscho EW, Pollock DM. Regulation of blood pressure and salt homeostasis by
endothelin. Physiol Rev. 2011;91:1-77.
2. Rosanò L, Cianfrocca R, Tocci P, Spinella F, Di Castro V, Caprara Vet al.Bagnato A. Endothelin A
receptor/ β -arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to
chemotherapy. Cancer Res. 2014;74:7453-7464.
Page 16/25
29. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. Occludin: a novel integral
membrane protein localizing at tight junctions. J Cell Biol. 1993;123:1777-1788.
30. Paku ł a M, Witucka A, Uruski P, Radziemski A, Moszy ń ski R, Szpurek Det al.Ksi ąż ek K. Senescence-
related deterioration of intercellular junctions in the peritoneal mesothelium promotes the
transmesothelial invasion of ovarian cancer cells. Sci Rep. 2019;9:7587.
31. Tobioka H, Isomura H, Kokai Y, Tokunaga Y, Yamaguchi J, Sawada N. Occludin expression decreases
with the progression of human endometrial carcinoma. Hum Pathol. 2004;35:159-164.
32. Osanai M, Murata M, Nishikiori N, Chiba H, Kojima T, Sawada N. Epigenetic silencing of occludin
promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of
apoptosis-associated genes. Cancer Res. 2006;66:9125-9133.
33. Martin TA, Mansel RE, Jiang WG. Loss of occludin leads to the progression of human breast cancer.
Int J Mol Med. 2010;26:723-734.
34. St Paul M, Ohashi PS. The Roles of CD8(+) T Cell Subsets in Antitumor Immunity. Trends Cell Biol.
2020;30:695-704.
35. Albertsson PA, Basse PH, Hokland M, Goldfarb RH, Nagelkerke JF, Nannmark U, Kuppen PJ. NK cells
and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends
Immunol. 2003;24:603-609.
3. Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer.
2016;16:7-19.
37. Zhang Z, Huang L, Brayboy L. Macrophages: an indispensable piece of ovarian health. Biol Reprod.
2021;104:527-538.
3. Puthenveetil A, Dubey S. Metabolic reprograming of tumor-associated macrophages. Ann Transl
Med. 2020;8:1030.
39. Ch'ng S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast cells and cutaneous malignancies. Mod Pathol.
2006;19:149-159.
40. Chan JK, Magistris A, Loizzi V, Lin F, Rutgers J, Osann Ket al.Samoszuk M. Mast cell density,
angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol Oncol.
2005;99:20-25.
Figures
Page 17/25
Figure 1
Study owchart.
Page 18/25
Figure 2
Identication of modules linked to clinical features of endometriosis in the GSE5108 dataset and ovarian
cancer in the GSE18520 dataset by WGCNA. (A, B) Determining the appropriate “soft” threshold ( β ) that
satised a scale-free network. (C, D) Co-expression module clustering in endometriosis (C) and ovarian
cancer (D). Each branch represented each gene, and genes clustered into the same module were assigned
the same color. (E, F) Heap of module–trait relationships in endometriosis (E) and ovarian cancer (F). (G,
Page 19/25
H) Scatter plots for the relationships of module membership in the black module and blue module with
gene signicance for (G) endometriosis and (H) ovarian cancer.
Figure 3
Functional enrichment analysis and identication of DEGs between endometriosis and EAOC. (A) GO
enrichment analysis. (B) KEGG pathways enrichment analysis. (C) Volcano diagram shows the DEGs in
endometriosis and EAOC. (D) Heatmap shows the top 30 up-regulated and down-regulated DEGs in
endometriosis and EAOC. (E) A total of 116 common genes were identied after intersection of genes
Page 20/25
from three datasets. (F) 23 DEGs were selected for further analysis based on the intersection of genes
from four algorithms.
Figure 4
Machine learning algorithms for hub genes selection. (A) In the LASSO regression model, minimum
standard was adopted to obtain the value of the super parameter λ by 10-fold cross-validation. Twelve
genes were selected as the potential biomarkers with the lowest binominal deviation. (B) The overview of
Page 21/25
LASSO coecients. (C) Random forest construction. The number of trees used to build the random forest
was specied as 200 before making the prediction. (D) Four genes were identied based on SVM-RFE
with the lowest error. (E) The top 10 genes were selected based on the importance score of RF algorithm.
(F) Two hub genes (OCLN, EDNRA) were nally identied via intersection of three machine learning
algorithms.
Figure 5
Page 22/25
Nomogram construction and evaluation of diagnostic ability of hub genes. (A) Nomogram construction
for diagnosing EAOC based on two characteristic genes. (B) Calibration curve. (C) Decision curve analysis
(DCA). (D-F) ROC curves and AUCs were utilized in GSE157153 to evaluate the diagnostic performances
of OCLN (D), EDNRA (E), and Nomogram (F). (G-I) ROC curves and AUCs were applied in TCGA-OV to
evaluate the diagnostic performances of OCLN (G), EDNRA (H), and Nomogram (I). (J-L) ROC curves and
AUCs were used in GSE18520 to assess the diagnostic performances of OCLN (J), EDNRA (K), and
Nomogram (L).
Page 23/25
Figure 6
Immune cell inltration between endometriosis and EAOC groups. (A) The inltrating levels of 22 immune
cell types between endometriosis and EAOC groups via CIBERSORT deconvolution algorithm. (B-C)
Spearman analyses were conducted to investigate the correlation of OCLN (B) and ENDRA (C) with
immune cell inltration degree. (D) Correlation among 22 immune cells types, where red and blue denote
positive and negative correlations, respectively, and white denotes no correlation between the designated
immune cell populations.
Page 24/25
Figure 7
GSVA of hallmark gene sets between EAOC and endometriosis and GSEA functional analysis of hub
genes. (A, B) GSEA identied signaling pathways involved in the characteristic genes of ENDRA (A) and
OCLN (B). (C) GSVA of hallmark gene sets was conducted to reveal the differences in signaling pathways
between EAOC and endometriosis patients.
Page 25/25
Figure 8
The expression proles and validation of the two hub genes by immunohistochemistry analysis.
(A, B) The expression proles of EDNRA (A) and OCLN (B) in EAOC and endometriosis patients in
GSE157153 dataset. (C, D) The expression proles of EDNRA (C) and OCLN (D) in EAOC and control
groups in GSE18520 dataset. (E, F) The expression proles of EDNRA (E) and OCLN (F) in EAOC and
control groups in TCGA-OV cohort. (G, H) Kaplan-Meier curves were plotted to compare the overall
survival difference between high- and low-expression groups with regard to EDNRA (G) and OCLN (H). (I)
Immunohistochemistry of two hub genes in ovarian cancer tissues and control tissues from the Human
Protein Atlas database.
Supplementary Files
This is a list of supplementary les associated with this preprint. Click to download.
Additionalle1.tif
Additionalle2.tif
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.